Changeflow GovPing Healthcare & Life Sciences Calm Health App Mindfulness Study for Adults Wi...
Routine Notice Added Final

Calm Health App Mindfulness Study for Adults With Chronic Kidney Disease

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NIH ClinicalTrials.gov has registered NCT07541495, a study testing a digital mindfulness app called Calm Health among adults with chronic kidney disease. Participants will use the app for 6 weeks while wearing a wrist sensor that tracks sleep, physical activity, heart rate, and other health signals. The study will measure the app's acceptability and feasibility and whether it may improve stress, anxiety, and quality of life.

Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

NIH ClinicalTrials.gov registered a new study (NCT07541495) titled 'The Mindful Kidney' evaluating a digital mindfulness app called Calm Health among adults with chronic kidney disease. Participants will use the app for 6 weeks while wearing a wrist sensor tracking sleep, physical activity, heart rate, and other health signals, and will receive health coaching and a personalized report.

Affected parties include clinical investigators and patients interested in digital health interventions for chronic kidney disease. This is a registry entry documenting a study design and is informational in nature — it does not create compliance obligations.

Archived snapshot

Apr 21, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

The Mindful Kidney: Supporting Mindfulness for Adults With Chronic Kidney Disease

N/A NCT07541495 Kind: NA Apr 21, 2026

Abstract

This study tests a digital mindfulness app called Calm Health among adults with chronic kidney disease (CKD). Participants will use the app for 6 weeks while wearing a wrist sensor that tracks sleep, physical activity, heart rate, and other health signals. The study will measure how acceptable and feasible the app is, and whether it may improve stress, anxiety, and quality of life. Participants will also receive health coaching and a personalized report showing how their mindfulness practice relates to their health data.

Conditions: Chronic Kidney Disease

Interventions: Mindfulness

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 21st, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers Patients Clinical investigators
Industry sector
3254.1 Biotechnology
Activity scope
Clinical research Digital health Mindfulness intervention
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals Clinical Trials

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!